What Citius Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Holuka Eugene Myron | Director | Mar 13 | Withheld — tax / exercise cost · F | −48 | $0.75 | −$36 | 2,367 |
| Holuka Eugene Myron | Director | Mar 13 | Exercise / conversion · M | +2,415 | $0.02 | +$36.2 | 2,415 |
| Webb Carol | Director | Mar 04 | Withheld — tax / exercise cost · F | −236 | $0.77 | −$181 | 11,835 |
| Webb Carol | Director | Mar 04 | Exercise / conversion · M | +12,071 | $0.02 | +$181 | 12,071 |
| Holubiak Myron Z | President and CEO | Sep 27 | Open-market buy · P | +558,597 | $0.90 | +$500K | 1,992,243 |
| Mazur Leonard L | Executive Chairman | Sep 27 | Open-market buy · P | +2,234,700 | $0.90 | +$2M | 10,255,343 |
| Holubiak Myron Z | President and CEO | Apr 03 | Open-market buy · P | +129,450 | $1.55 | +$200K | 1,433,646 |
| Mazur Leonard L | Executive Chairman | Apr 03 | Open-market buy · P | +1,165,048 | $1.55 | +$1.8M | 8,020,643 |
| Holubiak Myron Z | President and CEO | Aug 13 | Open-market buy · P | +784,314 | $1.28 | +$1M | 1,304,196 |
| Mazur Leonard L | Executive Chairman | Aug 13 | Open-market buy · P | +3,137,255 | $1.28 | +$4M | 6,855,595 |
| Mazur Leonard L | Executive Chairman | Mar 29 | Open-market buy · P | +167,504 | $2.99 | +$500K | 3,718,340 |
| Holubiak Myron Z | President and CEO | Mar 28 | Open-market buy · P | +2,915 | $3.09 | +$9.01K | 519,882 |
| Mazur Leonard L | Executive Chairman | Dec 19 | Open-market buy · P | +213,106 | $4.69 | +$999K | 3,550,836 |
| Mazur Leonard L | Executive Chairman | Aug 24 | Open-market buy · P | +11,000 | $2.68 | +$29.5K | 3,337,730 |
| Mazur Leonard L | Executive Chairman | Aug 08 | Derivative Conversion · C | +1,547,067 | $3.09 | +$4.78M | 3,326,730 |
| Mazur Leonard L | Executive Chairman | Aug 08 | Open-market buy · P | +421,400 | $4.13 | +$1.74M | 1,779,663 |
| Holubiak Myron Z | President and CEO | Mar 30 | Other Transaction · J | +7,754,497 | — | — | 7,754,497 |
| Mazur Leonard L | Director | Mar 30 | Other Transaction · J | +15,116,746 | — | — | 20,116,746 |
| Mazur Leonard L | Director | Mar 30 | Open-market buy · P | +5,000,000 | $0.60 | +$3M | 5,457,143 |
Loading...